Evidence map›Paper›PMID 35268504›Full record

ArticleJournal of clinical medicine2022

Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing.

Enric Sánchez, Esther Sapiña-Beltrán, Ricard Gavaldà, Ferran Barbé, Gerard Torres, Ariadna Sauret, Mireia Dalmases, Carolina López-Cano, Liliana Gutiérrez-Carrasquilla, Marcelino Bermúdez-López and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Enric SánchezEndocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.ORCID 0000-0001-7345-1601
Esther Sapiña-BeltránUniversity of Lleida, 25003 Lleida, Spain.ORCID 0000-0002-0053-266X
Ricard GavaldàAmalfi Analytics, Polytechnic University of Catalonia, 08034 Barcelona, Spain.
Ferran BarbéUniversity of Lleida, 25003 Lleida, Spain.
Gerard TorresUniversity of Lleida, 25003 Lleida, Spain.
Ariadna SauretEndocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Mireia DalmasesUniversity of Lleida, 25003 Lleida, Spain.
Carolina López-CanoEndocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.ORCID 0000-0001-7458-5871
Liliana Gutiérrez-CarrasquillaEndocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.
Marcelino Bermúdez-LópezVascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Elvira FernándezVascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Francisco PurroyUniversity of Lleida, 25003 Lleida, Spain.
Eva Castro-BoquéVascular and Renal Translational Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.ORCID 0000-0002-1013-0007
Cristina Farràs-SallésApplied Epidemiology Research Group, Institut de Recerca Biomèdica de Lleida (IRBLleida), 25198 Lleida, Spain.
Reinald PamplonaUniversity of Lleida, 25003 Lleida, Spain.ORCID 0000-0003-4337-6107
Dídac MauricioDepartment of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0002-2868-0250
Cristina HernándezCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0002-3109-1721
Rafael SimóCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0003-0475-3096
Albert LecubeEndocrinology and Nutrition Department, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.ORCID 0000-0001-9684-0183
On Behalf Of The Ilervas Project Collaborators
Universitat de Lleida · ESInstituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ESHospital Universitari Arnau de Vilanova · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESUniversitat Politècnica de Catalunya · ES

Funding

Instituto de Salud Carlos III PI12/00803, PI15/00260 and PI18/00964Lleida Provincial Council, Autonomous Government of Catalonia 2017SGR696 and SLT0021600250
6 · The paper itself

Abstract

Type 2 diabetes leads to severe nocturnal hypoxemia, with an increase in apnea events and daytime sleepiness. Hence, we assessed sleep breathing parameters in the prediabetes stage. A cross-sectional study conducted on 966 middle-aged subjects without known pulmonary disease (311 patients with prediabetes and 655 controls with normal glucose metabolism) was conducted. Prediabetes was defined by glycated hemoglobin (HbA1c), and a nonattended overnight home sleep study was performed. Participants with prediabetes (n = 311) displayed a higher apnea−hypopnea index (AHI: 12.7 (6.1;24.3) vs. 9.5 (4.2;19.6) events/h, p < 0.001) and hypopnea index (HI: 8.4 (4.0;14.9) vs. 6.0 (2.7;12.6) events/h, p < 0.001) than controls, without differences in the apnea index. Altogether, the prevalence of obstructive sleep apnea was higher in subjects with prediabetes than in controls (78.1 vs. 69.9%, p = 0.007). Additionally, subjects with prediabetes presented impaired measurements of the median and minimum nocturnal oxygen saturation, the percentage of time spent with oxygen saturations below 90%, and the 4% oxygen desaturation index in comparison with individuals without prediabetes (p < 0.001 for all). After adjusting for age, sex, and the presence of obesity, HbA1c correlated with the HI in the entire population (r = 0.141, p < 0.001), and the presence of prediabetes was independently associated with the AHI (B = 2.20 (0.10 to 4.31), p = 0.040) as well as the HI (B = 1.87 (0.61 to 3.14), p = 0.004) in the multiple linear regression model. We conclude that prediabetes is an independent risk factor for an increased AHI after adjusting for age, sex, and obesity. The enhanced AHI is mainly associated with increments in the hypopnea events.

Indexed as

apneaglycated hemoglobinhypopneaobstructive sleep apneaprediabetes

Identifiers

PMID35268504
PMCPMC8910907
OpenAlexW4220850004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.